Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep3-2026a10006hk. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Psoriasis https://emedicine.medscape.com/article/1943419-overview

Psoriasis: An Update on Topical and Systemic Therapies https://pubmed.ncbi.nlm.nih.gov/40568686/

Crosstalk Between White Adipose Tissue and Skin: Unraveling Its Role in Psoriasis Pathogenesis (Review) https://pubmed.ncbi.nlm.nih.gov/40242953/

Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis With Biologics https://pubmed.ncbi.nlm.nih.gov/30772098/

Joint American Academy of Dermatology-National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologic Therapies https://pubmed.ncbi.nlm.nih.gov/32119894/

Oral Janus Kinase Inhibitors in the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis https://pubmed.ncbi.nlm.nih.gov/36751339/

Janus Kinase Inhibitors for Alopecia Areata: A Review of Clinical Data https://pubmed.ncbi.nlm.nih.gov/40433365/

Herpes Zoster https://emedicine.medscape.com/article/1132465-overview

Clinical Testing Guidance for Tuberculosis: Interferon Gamma Release Assay https://www.cdc.gov/tb/hcp/testing-diagnosis/interferon-gamma-release-assay.html

Utility of Repeat Latent Tuberculosis Testing With the QuantiFERON-TB Gold Test in Patients With Psoriasis Treated With Tumour Necrosis Factor-α Inhibitors at a Single U.S. Institution https://pubmed.ncbi.nlm.nih.gov/31452192/

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Drs Steven Feldman and Tina Bhutani-Jacques explore how next-generation oral therapies are closing the gap with biologics and reshaping psoriasis care.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Acitretin Revisited in the Era of Biologics https://pubmed.ncbi.nlm.nih.gov/20673152/

Apremilast in Psoriasis: Current Landscape and Perspectives https://pubmed.ncbi.nlm.nih.gov/40739686/

Deucravacitinib Versus Placebo and Apremilast in Moderate-to-Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial https://pubmed.ncbi.nlm.nih.gov/35820547/

Apremilast Prescribing Information https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf

Deucravacitinib Prescribing Information https://packageinserts.bms.com/pi/pi_sotyktu.pdf

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39167366/

Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/

National Psoriasis Foundation https://www.psoriasis.org/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Drs Steven Feldman and Bernard Vrijens as they discuss the theory and practice of improving treatment adherence for better patient outcomes in psoriasis.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep1-2026a10006a1. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.  

Resources

Psoriasis https://emedicine.medscape.com/article/1943419-overview

The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results https://pubmed.ncbi.nlm.nih.gov/38135800/

Comparing Compliance Patterns Between Randomized Treatments https://pubmed.ncbi.nlm.nih.gov/9204220/

A Scoping Review of Studies Comparing the Medication Event Monitoring System (MEMS) With Alternative Methods for Measuring Medication Adherence https://pubmed.ncbi.nlm.nih.gov/27005306/

A New Taxonomy for Describing and Defining Adherence to Medications https://pubmed.ncbi.nlm.nih.gov/22486599/

One in 3 Prescriptions Are Never Redeemed: Primary Nonadherence in an Outpatient Clinic https://pubmed.ncbi.nlm.nih.gov/18467003/

Data Resource Profile: The Danish National Prescription Registry https://pubmed.ncbi.nlm.nih.gov/27789670/

Tachyphylaxis to Topical Glucocorticoids; What Is the Evidence? https://pubmed.ncbi.nlm.nih.gov/24010503/

Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/

10 Tips to Improve Adherence to Immunosuppressive Medication After Kidney Transplantation https://pubmed.ncbi.nlm.nih.gov/40521289/

The Health Buddies App as a Novel Tool to Improve Adherence and Knowledge in Atrial Fibrillation Patients: A Pilot Study https://pubmed.ncbi.nlm.nih.gov/28724512/

6MP Adherence in a Multiracial Cohort of Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study https://pubmed.ncbi.nlm.nih.gov/24829202/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep6-2026a100069z. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Psoriasis https://emedicine.medscape.com/article/1943419-overview

expertscape https://expertscape.com/

PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact https://pubmed.ncbi.nlm.nih.gov/40465498/

Topical Corticosteroids https://www.ncbi.nlm.nih.gov/books/NBK532940/

Psoriasis Clinical Guideline https://www.aad.org/member/clinical-quality/guidelines/psoriasis

Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies https://pubmed.ncbi.nlm.nih.gov/23425140/

Keratosis Pilaris https://emedicine.medscape.com/article/1070651-overview

Review of the Mechanism of Action of Coal Tar in Psoriasis https://pubmed.ncbi.nlm.nih.gov/28814117/

Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence https://pubmed.ncbi.nlm.nih.gov/28188596/

Polyaphron Dispersion Technology, a Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application https://pubmed.ncbi.nlm.nih.gov/36050567/

Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits https://pubmed.ncbi.nlm.nih.gov/34106439/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Drs Steve Feldman and Alexis Ogdie as they explore digital tools that detect and monitor psoriasis and psoriatic arthritis — using only a smartphone, movement, and a few taps.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep5-2026a100069y. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study https://pubmed.ncbi.nlm.nih.gov/38879192/

Psorcast https://apps.apple.com/us/app/psorcast/id1473504102

Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings https://pubmed.ncbi.nlm.nih.gov/39301469/

Sleep Problems in Patients With Psoriatic Arthritis: A Systematic Literature Review and Metaanalysis https://pubmed.ncbi.nlm.nih.gov/37127321/

The Impact of Dietary Interventions in Psoriatic Arthritis https://pubmed.ncbi.nlm.nih.gov/37339523/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr Feldman is joined by Drs Luke Johnson and Michelle Tarbox of the popular podcast Dermasphere, to discuss trends and hot topics in psoriasis.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep4-2026a100069r. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Dermasphere - The Derm Podcast https://dermaspherepodcast.com/

Skincast https://healthcare.utah.edu/dermatology/skincast

Bimekizumab in Patients With Psoriatic Arthritis, Naive to Biologic Treatment: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial (BE OPTIMAL) https://pubmed.ncbi.nlm.nih.gov/36493791/

Inflammatory Bowel Disease Induced by Bimekizumab https://pubmed.ncbi.nlm.nih.gov/35664026/

Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells https://pubmed.ncbi.nlm.nih.gov/32057839/

Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives https://pubmed.ncbi.nlm.nih.gov/35769285/

The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy https://pubmed.ncbi.nlm.nih.gov/27474032/

Deucravacitinib Versus Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial https://pubmed.ncbi.nlm.nih.gov/35820547/

Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/

Callus and Its Keratin Before and After Treatment With Acid Sodium Thioglycolate. A Study by Scanning and Conventional Electron Microscopy https://pubmed.ncbi.nlm.nih.gov/5132158/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

 Join Drs Steven Feldman and John Koo as they discuss psychodermatology and the link between psoriasis, anxiety, depression, and other mental health conditions.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep3-2026a100069f. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Psoriasis https://emedicine.medscape.com/article/1943419-overview

Management of Psychodermatologic Disorders https://www.medscape.com/viewarticle/730033\_5

Association Between Psoriasis and Depression: A Traditional Review https://pubmed.ncbi.nlm.nih.gov/32944430/

The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials https://pubmed.ncbi.nlm.nih.gov/38616886/

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis https://pubmed.ncbi.nlm.nih.gov/23892536/

Biologic Treatments of Psoriasis: An Update for the Clinician https://pubmed.ncbi.nlm.nih.gov/33623366/

Role of Janus Kinase Inhibitors in Therapy of Psoriasis https://pubmed.ncbi.nlm.nih.gov/34640327/

Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis With Comorbid Conditions and Special Populations: A Review https://pubmed.ncbi.nlm.nih.gov/33861409/

Depression and Suicidality in Psoriasis and Clinical Studies of Brodalumab: A Narrative Review https://pubmed.ncbi.nlm.nih.gov/31939925/

Use of the Patient Health Questionnaire (PHQ-9) in Practice: Interactions Between Patients and Physicians https://pubmed.ncbi.nlm.nih.gov/32564676/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to care people with psoriasis face.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep1-2026a100065h. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications https://pubmed.ncbi.nlm.nih.gov/29490358/

Ciclopirox Nail Lacquer Topical Solution 8% in the Treatment of Toenail Onychomycosis https://pubmed.ncbi.nlm.nih.gov/11051136/

Efinaconazole in Onychomycosis https://pubmed.ncbi.nlm.nih.gov/34902110/

Cost Effectiveness of Oral Terbinafine (Lamisil) Compared With Oral Fluconazole (Diflucan) in the Treatment of Patients With Toenail Onychomycosis https://pubmed.ncbi.nlm.nih.gov/11994041/

Prescription Cost-Saving Platforms in Dermatology https://pubmed.ncbi.nlm.nih.gov/39259524/

GoodRx https://www.goodrx.com

Mark Cuban CostPlus Drug Company https://www.costplusdrugs.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep2-2026a100065l. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Psoriasis https://emedicine.medscape.com/article/1943419-overview

Medscape InDiscussion: Obesity https://www.medscape.com/viewarticle/982631

Update on Obesity in Psoriasis Patients https://pubmed.ncbi.nlm.nih.gov/37895330/

Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023 https://www.cdc.gov/nchs/data/databriefs/db508.pdf

Obesity-Related Complications, Healthcare Resource Use and Weight Loss Strategies in Six European Countries: The RESOURCE Survey https://pubmed.ncbi.nlm.nih.gov/37258646/

The Link Between Obesity and the Skin https://pubmed.ncbi.nlm.nih.gov/35369048/

Acanthosis Nigricans https://emedicine.medscape.com/article/1102488-overview

Medications for Obesity: A Review https://pubmed.ncbi.nlm.nih.gov/39037780/

The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials https://pubmed.ncbi.nlm.nih.gov/38616886/

Role of the Gut-Brain Axis in Energy and Glucose Metabolism https://pubmed.ncbi.nlm.nih.gov/35474341/

Hidradenitis Suppurativa https://emedicine.medscape.com/article/1073117-overview

Biomarkers of Inflammation in Obesity-Psoriatic Patients https://pubmed.ncbi.nlm.nih.gov/31275060/

Robert Kushner, MD https://drrobertkushner.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Drs Steve Feldman and Megan Noe fill in the gaps about pustular psoriasis, a relatively rare but serious condition that can be tough to diagnose.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep6-2026a10005nc). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Palmoplantar Pustulosis: Current Understanding of Disease Definition and Pathomechanism https://pubmed.ncbi.nlm.nih.gov/32201085/

Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655659/

Pathophysiology of Generalized Pustular Psoriasis https://pubmed.ncbi.nlm.nih.gov/36779688/

Trial of Spesolimab for Generalized Pustular Psoriasis https://pubmed.ncbi.nlm.nih.gov/34936739/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Drs Steve Feldman and Andrew Blauvelt have a fascinating chat about contrasts and similarities between biologics and biosimilars, covering pharmacoeconomic and legal differences between the US and Europe.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep5-2026a10005mx). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future https://pubmed.ncbi.nlm.nih.gov/29549597/

International Psoriasis Council https://psoriasiscouncil.org/

Biosimilars for Psoriasis: Clinical Studies to Determine Similarity https://pubmed.ncbi.nlm.nih.gov/27639072/

Safety, Efficacy and Drug Survival of Biologics and Biosimilars for Moderate-to-severe Plaque Psoriasis https://pubmed.ncbi.nlm.nih.gov/29094341/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.